Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Journey Medical (DERM) Tax Provisions (2020 - 2025)

Journey Medical filings provide 5 years of Tax Provisions readings, the most recent being $60000.0 for Q2 2025.

  • On a quarterly basis, Tax Provisions changed N/A to $60000.0 in Q2 2025 year-over-year; TTM through Dec 2025 was $186000.0, a N/A change, with the full-year FY2025 number at $60000.0, changed 0.0% from a year prior.
  • Tax Provisions hit $60000.0 in Q2 2025 for Journey Medical, down from $126000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $8.3 million in Q4 2021 to a low of -$3.4 million in Q2 2021.
  • Median Tax Provisions over the past 4 years was $60000.0 (2025), compared with a mean of $179818.2.
  • Biggest five-year swings in Tax Provisions: crashed 14773.91% in 2021 and later soared 869.23% in 2023.
  • Journey Medical's Tax Provisions stood at $8.3 million in 2021, then crashed by 99.84% to $13000.0 in 2022, then soared by 869.23% to $126000.0 in 2023, then plummeted by 52.38% to $60000.0 in 2025.
  • The last three reported values for Tax Provisions were $60000.0 (Q2 2025), $126000.0 (Q4 2023), and $95000.0 (Q3 2023) per Business Quant data.